These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
381 related items for PubMed ID: 19713086
1. Effectiveness of teicoplanin versus vancomycin lock therapy in the treatment of port-related coagulase-negative staphylococci bacteraemia: a prospective case-series analysis. Del Pozo JL, García Cenoz M, Hernáez S, Martínez A, Serrera A, Aguinaga A, Alonso M, Leiva J. Int J Antimicrob Agents; 2009 Nov; 34(5):482-5. PubMed ID: 19713086 [Abstract] [Full Text] [Related]
2. Clinical efficacy of teicoplanin in the treatment of bloodstream infection caused by methicillin-resistant coagulase-negative staphylococci. Yamada K, Ueda T, Nakajima K, Ichiki K, Tsuchida T, Otani N, Takahashi Y, Ikeuchi H, Uchino M, Koshiba M, Takesue Y. J Infect Chemother; 2020 May; 26(5):459-464. PubMed ID: 31870587 [Abstract] [Full Text] [Related]
3. In Vivo Effectiveness of Several Antimicrobial Locks To Eradicate Intravascular Catheter Coagulase-Negative Staphylococci Biofilms. Blanco-Di Matteo A, Garcia-Fernandez N, Aguinaga Pérez A, Carmona-Torre F, Oteiza AC, Leiva J, Del Pozo JL. Antimicrob Agents Chemother; 2023 Jan 24; 67(1):e0126422. PubMed ID: 36602372 [Abstract] [Full Text] [Related]
4. Effectiveness of the antibiotic lock therapy for the treatment of port-related enterococci, Gram-negative, or Gram-positive bacilli bloodstream infections. Del Pozo JL, Alonso M, Serrera A, Hernaez S, Aguinaga A, Leiva J. Diagn Microbiol Infect Dis; 2009 Feb 24; 63(2):208-12. PubMed ID: 19026506 [Abstract] [Full Text] [Related]
5. A randomized clinical trial to compare fleroxacin-rifampicin with flucloxacillin or vancomycin for the treatment of staphylococcal infection. Schrenzel J, Harbarth S, Schockmel G, Genné D, Bregenzer T, Flueckiger U, Petignat C, Jacobs F, Francioli P, Zimmerli W, Lew DP, Swiss Staphylococcal Study Group. Clin Infect Dis; 2004 Nov 01; 39(9):1285-92. PubMed ID: 15494904 [Abstract] [Full Text] [Related]
6. Antibiotic-lock therapy for long-term intravascular catheter-related bacteraemia: results of an open, non-comparative study. Fernandez-Hidalgo N, Almirante B, Calleja R, Ruiz I, Planes AM, Rodriguez D, Pigrau C, Pahissa A. J Antimicrob Chemother; 2006 Jun 01; 57(6):1172-80. PubMed ID: 16597634 [Abstract] [Full Text] [Related]
7. Treatment of long-term intravascular catheter-related bacteraemia with antibiotic lock: randomized, placebo-controlled trial. Rijnders BJ, Van Wijngaerden E, Vandecasteele SJ, Stas M, Peetermans WE. J Antimicrob Chemother; 2005 Jan 01; 55(1):90-4. PubMed ID: 15574481 [Abstract] [Full Text] [Related]
8. Treatment of infective endocarditis caused by methicillin-resistant Staphylococcus aureus: teicoplanin versus vancomycin in a retrospective study. Huang JH, Hsu RB. Scand J Infect Dis; 2008 Jan 01; 40(6-7):462-7. PubMed ID: 18584532 [Abstract] [Full Text] [Related]
9. Characterisation of coagulase-negative staphylococci isolated from blood infections: incidence, susceptibility to glycopeptides, and molecular epidemiology. Boisson K, Thouverez M, Talon D, Bertrand X. Eur J Clin Microbiol Infect Dis; 2002 Sep 01; 21(9):660-5. PubMed ID: 12373498 [Abstract] [Full Text] [Related]
10. Catheter-related bacteremia caused by methicillin-resistant coagulase negative staphylococci with elevated minimal inhibitory concentration for vancomycin. Castagnola E, Bandettini R, Lorenzi I, Caviglia I, Macrina G, Tacchella A. Pediatr Infect Dis J; 2010 Nov 01; 29(11):1047-8. PubMed ID: 20581735 [Abstract] [Full Text] [Related]
11. Treatment of long-term intravascular catheter-related bacteraemia with antibiotic-lock therapy. Fortún J, Grill F, Martín-Dávila P, Blázquez J, Tato M, Sánchez-Corral J, García-San Miguel L, Moreno S. J Antimicrob Chemother; 2006 Oct 01; 58(4):816-21. PubMed ID: 16899468 [Abstract] [Full Text] [Related]
12. Glycopeptide resistance among coagulase-negative staphylococci that cause bacteremia: epidemiological and clinical findings from a case-control study. Tacconelli E, Tumbarello M, Donati KG, Bettio M, Spanu T, Leone F, Sechi LA, Zanetti S, Fadda G, Cauda R. Clin Infect Dis; 2001 Nov 15; 33(10):1628-35. PubMed ID: 11595984 [Abstract] [Full Text] [Related]
14. [Use of glycopeptides in the treatment of infections caused by methicillin-resistant staphylococci]. Bouza E, Rodríguez-Créixems M, Muñoz P. Rev Clin Esp; 1997 Sep 15; 197 Suppl 2():52-8. PubMed ID: 9441324 [No Abstract] [Full Text] [Related]
15. Nephrotoxicity of vancomycin in patients with methicillin-resistant Staphylococcus aureus bacteraemia. Shen WC, Chiang YC, Chen HY, Chen TH, Yu FL, Tang CH, Sue YM. Nephrology (Carlton); 2011 Nov 15; 16(8):697-703. PubMed ID: 21707841 [Abstract] [Full Text] [Related]
16. [Adequate intrathecal diffusion of teicoplanin after failure of vancomycin, administered in continuous infusion in three cases of shunt associated meningitis]. Jourdan C, Convert J, Peloux A, Boussaid O, Grando J, Tigaud S. Pathol Biol (Paris); 1996 May 15; 44(5):389-92. PubMed ID: 8758482 [Abstract] [Full Text] [Related]
17. Tolerability of teicoplanin in 117 hospitalized adults with previous vancomycin-induced fever, rash, or neutropenia: a retrospective chart review. Hung YP, Lee NY, Chang CM, Lee HC, Wu CJ, Chen PL, Lee CC, Chung CH, Ko WC. Clin Ther; 2009 Sep 15; 31(9):1977-86. PubMed ID: 19843487 [Abstract] [Full Text] [Related]
18. Tolerance to the glycopeptides vancomycin and teicoplanin in coagulase-negative staphylococci. Bourgeois I, Pestel-Caron M, Lemeland JF, Pons JL, Caron F. Antimicrob Agents Chemother; 2007 Feb 15; 51(2):740-3. PubMed ID: 17116684 [Abstract] [Full Text] [Related]
19. Pulsed field gel electrophoresis typing of coagulase-negative staphylococci with decreased susceptibility to teicoplanin isolated from an intensive care unit. Schlegel L, Saliba F, Mangeney N, Mathieu D. J Hosp Infect; 2001 Sep 15; 49(1):62-8. PubMed ID: 11516189 [Abstract] [Full Text] [Related]
20. Management of the catheter in documented catheter-related coagulase-negative staphylococcal bacteremia: remove or retain? Raad I, Kassar R, Ghannam D, Chaftari AM, Hachem R, Jiang Y. Clin Infect Dis; 2009 Oct 15; 49(8):1187-94. PubMed ID: 19780661 [Abstract] [Full Text] [Related] Page: [Next] [New Search]